Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Immunotherapy. 2011 Oct;3(10):1265-74. doi: 10.2217/imt.11.113.

Chronic inflammation and immunologic-based constraints in malignant disease.

Author information

  • 1Department of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.

Abstract

Acute inflammatory reactions benefit the host by supporting the effective clearance of pathogens and fostering wound healing, in addition to other self-preservative processes. However, when the inflammatory program is not resolved, becoming chronic in nature, it creates an environment conducive to cancer development and progression. Therefore, minimizing exposure to risk factors that contribute to chronic inflammation and reconditioning the host towards a state of (at least locoregional) acute inflammation would meaningfully impact cancer incidence and its treatment, respectively. Regarding cancer therapy, combinational treatments that both disrupt chronic inflammation and install specific adaptive type I immunity are predicted to enhance quality of life and extend the overall survival of patients.

PMID:
21995576
[PubMed - indexed for MEDLINE]
PMCID:
PMC3225121
Free PMC Article

Images from this publication.See all images (2)Free text

Figure 1
Figure 2
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon Icon for PubMed Central
    Loading ...
    Write to the Help Desk